Thrombopoietin in the fetus and neonate

Early Human Development

Volumn 59, Issue 1, 2000, Pages 1-12

  Murray, Neil A ^a   Watts, Timothy L ^a   Roberts, Irene A G ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Fetus; Newborn; Thrombopoietin

Indexed keywords

MESSENGER RNA; THROMBOPOIETIN;

FETUS; FETUS LIVER; HORMONE BLOOD LEVEL; HORMONE STRUCTURE; HUMAN; MEGAKARYOCYTE; MEGAKARYOPOIESIS; NEWBORN; NONHUMAN; ONTOGENY; PROTEIN EXPRESSION; PROTEIN METABOLISM; RECEPTOR BINDING; REGULATORY MECHANISM; REVIEW; RHESUS MONKEY; SPECIES DIFFERENCE; STEM CELL; THROMBOCYTE; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS;

ADULT; ANIMALS; ANIMALS, NEWBORN; FEMALE; FETUS; HUMANS; INFANT, NEWBORN; PREGNANCY; THROMBOPOIETIN;

EID: 0033837991     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-3782(00)00078-5     Document Type: Review

References (83)

1. Kelemen E., Cserhati I., Tanos B. Demonstration and some properties of human thrombopoietin in thrombocytopenic sera. Acta Haematol Basel. 20:1958;350.
2. Yamamoto S. Mechanism of the development of thrombocytosis due to bleeding. Acta Haematol Jpn. 20:1957;163.
3. Evatt B.L., Shreiner D.P., Levin J. Thrombopoietic activity of fractions of rabbit plasma: studies in rabbits and mice. J Lab Clin Med. 83:1974;364-371.
4. McDonald T.P. Assay of thrombopoietin utilising human sera and urine fractions. Biochem Med. 13:1975;101-110.
5. Nakeff A., Roozendaal K.J. Thrombopoietin activity in mice following immune-induced thrombocytopenia. Acta Haematol. 54:1975;340-344.
6. Vainchenker W., Bouguet J., Guichard J., Breton-Gorius J. Megakaryocyte colony formation from human bone marrow precursors. Blood. 54:1979;940-945.
7. Grossi A., Vannucchi A.M., Rossi-Ferrini P. Humoral regulation of megakaryocytopoiesis. Biotherapy. 2:1990;375-383.
8. Hoffman R. Regulation of megakaryocytopoiesis. Blood. 74:1989;1196-1212.
9. de Sauvage F.J., Hass P.E., Spencer S.D., Malloy B.E., Gurney A.L., Spencer S.A., Darbonne W.C., Henzel W.J., Wong S.C., Kuang W.-J., Oles K.J., Hultgren B., Solberg L.A. Jr., Goeddel D.V., Eaton D.L. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature. 369:1994;533-538.
10. Lok S., Kaushansky K., Holly R.D., Kuijper J.L., Lofton-Day C.E., Oort P.J., Grant F.J., Heipel M.D., Burkhead S.K., Kramer J.M., Bell L.A., Sprecher C.A., Blumberg H., Johnson R., Prunkard D., Ching A.F.T., Mathewes S.L., Bailey M.C., Forstrom J.W., Buddle M.M., Osborn S.G., Evans S.J., Sheppard P.O., Presnell S.R., O'Hara P.J., Hagen F.S., Roth G.J., Foster D.C. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature. 369:1994;565-568.
11. Kaushansky K., Lok S., Holly R.D., Broudy V.C., Lin N., Bailey M.C., Forstrom J.W., Buddle M.M., Oort P.J., Hagen F.S., Roth G.J., Papayannopoulou T., Foster D.C. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature. 369:1994;568-571.
12. Wendling F., Maraskovsky E., Debill N., Florindo C., Teepe M., Titeux M., Methia N., Breton-Gorius J., Cosman D., Vainchenker W. C-mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature. 369:1994;571-574.
13. Kaushansky K. Thrombopoietin. N Engl J Med. 339:1998;746-754.
14. Cohen-Solal K., Debili N., Vainchenker W., Wendling F. Thrombopoietin (Mpl-ligand) and the regulation of platelet production. Thromb Haemost. 78:1997;37-41.
15. Eaton D.L., de Sauvage F.J. Thrombopoietin: the primary regulator of megakaryocytopoiesis and thrombopoiesis. Exp Hematol. 25:1997;1-7.
16. Kaushansky K. Thrombopoietin and the hematopoietic stem cell. Blood. 92:1998;1-3.
17. Solar G.P., Kerr W.G., Zeigler F.C., Hess D., Donahue C., de-Sauvage F.J., Eaton D.L. Role of c-mpl in early hematopoiesis. Blood. 92:1998;4-10.
18. Ritchie A., Vadhan-Raj S., Broxmeyer H.E. Thrombopoietin suppresses apoptosis and behaves as a survival factor for the human growth-factor dependent cell line, MO7e. Stem Cells. 14:1996;330-336.
19. Ritchie A., Gotoh A., Gaddy J., Braun S.E., Broxmeyer H.E. Thrombopoietin upregulates the promoter conformation of p53 in a proliferation-independent manner coincident with decreased expression of Bax: potential mechanisms for survival enhancing effects. Blood. 90:1997;4394-4402.
20. Hann I.M. Development of blood in the fetus. Hann I.M., Gibson B.E.S., Letsky E.A. Fetal and Neonatal Haematology. 1st ed :1991;1-28 Bailliere Tindall.
21. Holmberg L., Gustavii B., Jonsson A. A prenatal study of fetal platelet count and size with application to the fetus at risk of Wiskott Aldrich syndrome. J Pediatr. 102:1983;773-781.
22. Forestier F., Daffos F., Galacteros F. Haematological values of 163 normal fetuses between 18 and 30 weeks of gestation. Pediatr Res. 20:1986;342-346.
23. Forestier F., Daffos F., Catherine N., Renard M., Andreux J.P. Developmental hematopoiesis in normal human fetal blood. Blood. 77:1991;2360-2363.
24. Hohlfeld P., Forestier F., Kaplan C., Tissot J.D., Daffos F. Fetal thrombocytopenia: a retrospective survey of 5,194 fetal blood samplings. Blood. 84:1994;1851-1856.
25. Burrows R.F., Kelton J.G. Incidentally detected thrombocytopenia in healthy mothers and their infants. N Engl J Med. 319:1988;142-145.
26. Burrows R.F., Kelton J.G. Thrombocytopenia at delivery: A prospective survey of 6715 deliveries. Am J Obstet Gynecol. 162:1990;731-734.
27. Burrows R.F., Kelton J.G. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med. 329:1993;1463-1466.
28. Castle V., Andrew M., Kelton J., Giron D., Johnson M., Carter C. Frequency and mechanism of neonatal thrombocytopenia. J Pediatr. 108:1986;749-755.
29. Metha P., Rohitkumar V., Neumann L., Karpatkin M. Thrombocytopenia in the high risk infant. J Pediatr. 97:1980;791-794.
30. Murray N.A., Roberts I.A.G. Circulating megakaryocytes and their progenitors in early thrombocytopenia in preterm neonates. Pediatr Res. 40:1996;112-119.
31. Andrew M., Castle V., Saigal S., Carter C., Kelton J. Clinical impact of neonatal thrombocytopenia. J Pediatr. 110:1987;457-464.
32. Homans A. Thrombocytopenia in the neonate. Pediatric Clin North Am. 43:1996;737-756.
33. Blanchette V.S., Rand M.L. Platelet disorders in newborn infants: diagnosis and management. Semin Perinatol. 21:1997;53-62.
34. Sola M.C., Calhoun D.A., Hutson A.D., Christensen R.D. Plasma thrombopoietin concentrations in thrombocytopenic and non-thrombocytopenic patients in a neonatal intensive care unit. Br J Haematol. 104:1999;90-92.
35. Murray N.A. New concepts in the aetiology and management of neonatal thrombocytopenia. Semin Neonatol. 4:1999;27-40.
36. Schnittger S., de-Sauvage F.J., Le-Paslier D., Fonatsch C. Refined chromosomal localization of the human thrombopoietin gene to 3q27-28 and exclusion as the responsible gene for thrombocytosis in patients with rearrangements of 3q21 and 3q26. Leukemia. 10:1996;1891-1896.
37. Bartley T.D., Bogenberger J., Hunt P., Li Y.-S., Lu H.S., Martin F., Chang M.-S., Samal B., Nichol J.L., Swift S., Johnson J., Hsu R.-Y., Parker V.P., Suggs S., Skrine J.D., Merewether L.A., Clogston C., Hsu E., Hokom M.M., Hornkohl A., Choi E., Pangelinan M., Sun Y., Mar V., McNinch J., Simonet L., Jacobsen F., Xie C., Shutter J., Chute H., Basu R., Selander L., Trollinger D., Sieu L., Padilla D., Trail G., Elliott G., Izumi R., Covey T., Crouse J., Garcia A., Xu W., Del Castillo J., Biron J., Cole S., Hu M.C.-T., Pacifici R., Ponting I., Saris C., Wen D., Yung Y.P., Lin H., Bosselman R.A. Identification and cloning of a megakaryocyte growth and development factor that is the ligand for the cytokine receptor Mpl. Cell. 77:1994;1117-1124.
38. Hokom M.A., Lacey D., Kinstler O.B., Choi E., Kaufman S., Faust J., Rowan C., Dwyer E., Nichol J.L., Grasel T., Wilson J., Steinbrink R., Hecht R., Winters D., Boone T., Hunt P. Pegylated megakaryocyte growth and development factor abrogates the lethal thrombocytopenia associated with carboplatin and irradiation in mice. Blood. 86:1995;4486-4492.
39. Thomas G.R., Thibodeaux H., Erret C.J., Mathias J., Marian M., Vandelen R.L., Eaton D.L. In vitro biological effects of various forms of thrombopoietin in a murine model of transient thrombocytopenia. Stem Cells. 14:(suppl 1):1996;244.
40. Zeigler F.C., de Sauvage F., Widmer H.R., Keller G.A., Donahue C., Schreiber R.D., Malloy B., Hass P., Eaton D., Matthews W. In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. Blood. 84:1994;4045-4052.
41. Debili N., Wendling F., Katz A., Guichard J., Brenton-Gorius J., Hunt P., Vainchenker W. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiation factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood. 86:1995;2516-2525.
42. Angchaisuksiri P., Carlson P.L., Dessypris E.N. Effects of recombinant thrombopoietin on megakaryocyte colony growth and megakaryocyte ploidy by human C.D. 34+ cells in a serum free system. Br J Haematol. 93:1996;13-17.
43. Choi E.S., Nichol J.L., Hokom M.M., Hornkohl A.C., Hunt P. Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood. 85:1995;402-413.
44. Murone M., Carpenter D.A., de-Sauvage F.J. Hematopoietic deficiencies in c-mpl and TPO knockout mice. Stem Cells. 16:1998;1-6.
45. Kuter D., McCullough J., Romo J., DiPeriso J., Peterson R., Armstrong S., Menchaca D., Tomita D., Goodnough L.T. Treatment of platelet (PLT) donors with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) increases circulating PLT counts (CTS) and PLT apheresis yields and increases platelet increments in recipients of PLT transfusions. Blood. 90:(Suppl 1):1997;579a.
46. Basser R.L., Rasko J.E., Clarke K., Cebon J., Green M.D., Hussein S., Alt C., Menchaca D., Tomita D., Marty J., Fox R.M., Begley C.G. Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer. Lancet. 348:1996;1279-1281.
47. Fanucchi M., Glaspy J., Crawford J., Garst J., Figlin R., Sheridan W., Menchaca D., Tomita D., Ozer H., Harker L. Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer. N Engl J Med. 336:1997;404-409.
48. Emmons R.V., Reid D.M., Cohen R.L., Meng G., Young N.S., Dunbar C.E., Shulman N.R. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood. 87:1996;4068-4071.
49. Walka M.M., Sonntag J., Dudenhausen J.W., Obladen M. Thrombopoietin concentration in umbilical cord blood of healthy term newborns is higher than in adult controls. Biol Neonate. 75:1999;54-58.
50. Griesshammer M., Hornkohl A., Nichol J.L., Hecht T., Raghavachar A., Heimpel H., Schrezenmeier H. High levels of thrombopoietin in sera of patients with essential thrombocythemia. Ann Hematol. 77:1998;211-215.
51. Tacke F., Schoffski P., Trautwein C., Martin M.U., Stangel W., Seifried E., Manns M.P., Ganser A., Petersen D. Endogenous serum levels of thrombopoietic cytokines in healthy whole-blood and platelet donors: implications for plateletpheresis. Br J Haematol. 105:1999;511-513.
52. Heits F., Stahl M., Ludwig D., Strange E.F., Jelkmann W. Elevated serum thrombopoietin and interleukin-6 concentrations in thrombocytosis associated with inflammatory bowel disease. J Interferon Cytokine Research. 19:1999;757-760.
53. Tahara T., Usuki K., Sato H., Ohashi H., Morita H., Tsumura H., Matsumoto A. A sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disorders. Br J Haematol. 93:1996;783-788.
54. Schrezenmeier H., Griesshammer M., Hornkohl A., Nichol J.L., Hecht T., Heimpel H., Kubanek B., Raghavachar A. Thrombopoietin serum levels in patients with aplastic anaemia: correlation with platelet count and persistent elevation in remission. Br J Haematol. 100:1998;571-576.
55. Hou M., Andersson P.O., Stockelberg D., Mellqvist U.H., Ridell B., Wadenvik H. Plasma thrombopoietin levels in thrombocytopenic states: implication for regulatory role of bone marrow megakaryocytes. Br J Haematol. 101:1998;420-424.
56. Koike Y., Yoneyama A., Shirai J., Isida T., Shoda E., Miyazaki K., Sunaga S., Horie R., Aoki K., Koike K., Ogata I., Tahara T., Kato T., Nakahara K., Kariya T., Higashihara M. Evaluation of thrombopoiesis in thrombocytopenic disorders by simultaneous measurement of reticulated platelets of whole blood and serum thrombopoietin concentrations. Throm Haemost. 79:1998;1106-1110.
57. Fielder P.J., Gurney A.L., Stefanich E., Marian M., Moore M.W., Carver-Moore K., de-Sauvage F.J. Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Blood. 87:1996;2154-2161.
58. Stoffel R., Wiestner A., Skoda R.C. Thrombopoietin in thrombocytopenic mice: Evidence against regulation at the mRNA level and for a direct role of platelets. Blood. 87:1996;567.
59. Nagata Y., Shozaki Y., Nagahisa H., Nagasawa T., Abe T., Todokoro K. Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis. Thromb Haemost. 77:1997;808-814.
60. Sato T., Fuse A., Niimi H., Fielder P.J., Avraham H. Binding and regulation of thrombopoietin to human megakaryocytes. Br J Haematol. 100:1998;704-711.
61. Takeshita A., Shinjo K., Naito K., Nakamura S., Izumi M., Ling P., Ohnishi K., Ohno R. Amount of mpl on bone marrow haemopoietic precursor cells from healthy volunteers and patients with refractory anaemia. Br J Haematol. 99:1997;746-755.
62. Broudy V.C., Lin N.L., Sabath D.F., Papayannopoulou T., Kaushansky K. Human platelets display high-affinity receptors for thrombopoietin. Blood. 89:1997;1896-1904.
63. Sola M.C., Juul S.E., Meng Y.G., Garg S., Sims P., Calhoun D.A., Dame J.B., Christensen R.D. Thrombopoietin (Tpo) in the fetus and neonate: Tpo concentrations in preterm and term neonates, and organ distribution of Tpo receptor (c-mpl) during human fetal development. Early Hum Dev. 53:1999;239-250.
64. Wolber E.-M., Bame C., Fahnenstich H., Hofmann D., Bartmann P., Jelkmann W., Fandrey J. Expression of the thrombopoietin gene in human fetal and neonatal tissues. Blood. 94:1999;97-105.
65. Nomura S., Ogami K., Kawamura K., Tsukamoto I., Kudo Y., Kanakura Y., Kitamura Y., Miyazaki H., Kato T. Cellular localisation of thrombopoietin mRNA in the liver by in situ hybridization. Exp Hematol. 25:1997;565-572.
66. Nagahisa H., Nagata Y., Ohnuki T., Osada M., Nagasawa T., Abe T., Todokoro K. Bone marrow stromal cells produce thrombopoietin and stimulate megakaryocyte growth and maturation but suppress proplatelet formation. Blood. 87:1996;1309-1316.
67. Guerriero A., Worford L., Holland H.K., Guo G.R., Sheehan K., Waller E.K. Thrombopoietin is synthesized by bone marrow stromal cells. Blood. 90:1997;3444-3455.
68. Campagnoli C., Fisk N., Overton T., Bennett P., Watts T.L., Roberts I.A.G. Circulating hematopoietic progenitor cells in first trimester fetal blood. Blood. 95:2000;1967-1972.
69. Murray N.A., Watts T.L., Roberts I.A.G. Endogenous thrombopoietin levels and effect of recombinant human thrombopoietin on megakaryocyte precursors in term and preterm babies. Pediatr Res. 43:1998;148-151.
70. Watts T.L., Murray N.A., Roberts I.A.G. Thrombopoietin has a primary role in the regulation of platelet production in preterm babies. Pediatr Res. 46:1999;28-32.
71. Nishihira H., Toyoda Y., Miyazaki H., Kigasawa H., Ohsaki E. Growth of macroscopic human megakaryocyte colonies from cord blood with recombinant human thrombopoietin (c-mpl ligand) and the effects of gestational age on the frequency of colonies. Br J Haematol. 92:1996;23-28.
72. Sola M.C., Du Y., Hutson A.D., Christensen R.D. Dose-response relationship of megakaryocyte progenitors from bone marrow and peripheral blood of thrombocytopenic neonates to recombinant thrombopoietin. Periatr Res. 45:1999;153A.
73. Watts T.L., Murray N.A., Roberts I.A.G. Thrombopoietin in term and preterm babies with and without thrombocytopenia. Blood. 90:1997;141a.
74. Sola M.C., Christensen R.D., Hutson A.D., Tarantal A.F. Pharmacokinetics, pharmacodynamics, and safety of administering pegylated recombinant megakaryocyte growth and development factor to newborn rhesus monkeys. Pediatr Res. 47:2000;208-214.
75. Colarizi P., Fiorucci P., Caradonna A., Ficuccilli F., Mancuso M., Papoff P. Circulating thrombopoietin levels in neonates with infection. Acta Paediatr. 88:1999;332-337.
76. Colarizi P., Fiorucci P., Roggini M., Papoff P. Circulating thrombopoietin levels in a neonate with osteopetrosis. Pediatrics. 103:1999;700-701.
77. Murray N.A., Roberts I.A.G. Circulating megakaryocytes and their progenitors (BFU-MK and CFU-MK) in term and pre-term neonates. Br J Haematol. 89:1995;41-46.
78. 15N]-methacetin urine test: influences of gestational age, postnatal age and intra-uterine growth retardation. Biol Neonate. 68:1995;19-25.
79. Desai M., Hales C.N. Role of fetal and infant growth in programming metabolism in later life. Biol Rev Camb Philos Soc. 72:1997;329-348.
80. Ihara K., Ishii E., Eguchi M., Takada H., Suminoe A., Good R.A., Hara T. Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia. Proc Natl Acad Sci USA. 96:1999;3132-3136.
81. Ballmaier M., Schulze H., Strauss G., Cherkaoui K., Wittner N., Lynen S., Wolters S., Bogenberger J., Welte K. Thrombopoietin in patients with congenital thrombocytopenia and absent radii: elevated serum levels, normal receptor expression, but defective reactivity to thrombopoietin. Blood. 90:1997;612-619.
82. Levy G.J., Strauss R.G., Hume H., Schloz L., Albanese M.A., Blazina J., Werner A., Sotelo-Avila C., Barrasso C., Blanchette V., Warkentin P.I., Pepkowitz S., Mauer A.M., Hines D. National survey of neonatal transfusion practices: II. Blood component therapy. Pediatrics. 91:1993;530-536.
83. Blanchette V.S., Kuhne T., Hume H., Hellmann J. Platelet transfusion therapy in newborn infants. Transfus Med Rev. 9:1995;215-230.